Cargando…

Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors

Detalles Bibliográficos
Autores principales: Winiszewski, Hadrien, Piton, Gael, Capellier, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578254/
https://www.ncbi.nlm.nih.gov/pubmed/36253862
http://dx.doi.org/10.1186/s13054-022-04181-z
_version_ 1784811933245898752
author Winiszewski, Hadrien
Piton, Gael
Capellier, Gilles
author_facet Winiszewski, Hadrien
Piton, Gael
Capellier, Gilles
author_sort Winiszewski, Hadrien
collection PubMed
description
format Online
Article
Text
id pubmed-9578254
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95782542022-10-19 Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors Winiszewski, Hadrien Piton, Gael Capellier, Gilles Crit Care Correspondence BioMed Central 2022-10-17 /pmc/articles/PMC9578254/ /pubmed/36253862 http://dx.doi.org/10.1186/s13054-022-04181-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correspondence
Winiszewski, Hadrien
Piton, Gael
Capellier, Gilles
Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors
title Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors
title_full Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors
title_fullStr Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors
title_full_unstemmed Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors
title_short Early hyperoxia and 28-day mortality in patients on venoarterial ECMO support for refractory cardiogenic shock: discussion about potential confounding factors
title_sort early hyperoxia and 28-day mortality in patients on venoarterial ecmo support for refractory cardiogenic shock: discussion about potential confounding factors
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578254/
https://www.ncbi.nlm.nih.gov/pubmed/36253862
http://dx.doi.org/10.1186/s13054-022-04181-z
work_keys_str_mv AT winiszewskihadrien earlyhyperoxiaand28daymortalityinpatientsonvenoarterialecmosupportforrefractorycardiogenicshockdiscussionaboutpotentialconfoundingfactors
AT pitongael earlyhyperoxiaand28daymortalityinpatientsonvenoarterialecmosupportforrefractorycardiogenicshockdiscussionaboutpotentialconfoundingfactors
AT capelliergilles earlyhyperoxiaand28daymortalityinpatientsonvenoarterialecmosupportforrefractorycardiogenicshockdiscussionaboutpotentialconfoundingfactors